Showing results (401-410 of 567) with videos related to
Sort By:
Pageof 57
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neckC Jacobs, G Lyman, E Velez-García, et al.Diabetologia|October 6, 2023
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetesVikas S Sridhar, Christine P Limonte, Per-Henrik Groop, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2011
A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07aK N Chi, E Beardsley, B J Eigl, et al.Cancer|January 6, 2017
Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancerBrandon Bernard, Vinayak Muralidhar, Yu-Hui Chen, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studiesK S Sridhar, A Krishan, T S Samy, et al.Cancer Investigation|January 1, 1996
Cisplatin and continuous infusion of fluorouracil followed by radiation and weekly carboplatin in the treatment of locally advanced head and neck cancer: a Hellenic Cooperative Oncology Group studyG Fountzilas, P Kosmidis, K S Sridhar, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 25, 2016
Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abirateroneFred Saad, Eric Winquist, Stacey Hubay, et al.BJU International|February 9, 2012
Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkersNeesha C Dhani, Urban Emmenegger, Laurie Adams, et al.Journal of Diabetes and Its Complications|March 8, 2021
Relationships between inflammation, hemodynamic function and RAAS in longstanding type 1 diabetes and diabetic kidney diseaseJaya Prakash Nath Ambinathan, Vikas S Sridhar, Yuliya Lytvyn, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 10, 2018
Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxelDaniel W Yokom, John Stewart, Nimira S Alimohamed, et al.Pageof 57